Mahvash disease: A novel case of apparent monoallelic disease and a novel cause of hypoglycaemia

Glucagon cell hyperplasia and neoplasia (GCHN), also known as Mahvash disease (MVAH), is a rare pancreatic neuroendocrine disorder. In most cases, the disorder is autosomal recessive and caused by inactivating mutations in the glucagon receptor (GCGR), leading to pancreatic α-cell hyperplasia and hyperglucagonemia, with sporadic association with hypoglycaemia. We present an adult female patient presenting with recurrent hypoglycaemia: she had an enlarged pancreas and very high levels of glucagon. Severe hypoglycaemia is not generally seen in most cases of Mahvash syndrome; this could suggest the possibility of an occult insulinoma. Genetic testing showed an essential splice variant in GCGR that predicts loss of protein production. It is most likely a single pathogenic variant in the GCGR gene, although the literature reports only a recessive phenotype. We cannot entirely exclude an autosomal recessive condition in terms of mutations in promoter or relevant intronic regions.

Authors

Institutions

Publication Details

Journal
Endocrine Oncology
Published
2026-10-26
DOI
https://doi.org/10.1530/eo-26-0063
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mahvash disease: A novel case of apparent monoallelic disease and a novel cause of hypoglycaemia

Bernard Chong Eu Khoo, Márta Korbonits, Martyn Evan Caplin, Ashley Barry Grossman et al.
Endocrine Oncology
Pancreatic function and diabetes
article

Mahvash disease: A novel case of apparent monoallelic disease and a novel cause of hypoglycaemia

Bernard Chong Eu Khoo, Márta Korbonits, Martyn Evan Caplin, Ashley Barry Grossman, Sayka Barry, Bano Gul, Heung Chong, N. Beharry
article en

Abstract

Glucagon cell hyperplasia and neoplasia (GCHN), also known as Mahvash disease (MVAH), is a rare pancreatic neuroendocrine disorder. In most cases, the disorder is autosomal recessive and caused by inactivating mutations in the glucagon receptor (GCGR), leading to pancreatic α-cell hyperplasia and hyperglucagonemia, with sporadic association with hypoglycaemia. We present an adult female patient presenting with recurrent hypoglycaemia: she had an enlarged pancreas and very high levels of glucagon. Severe hypoglycaemia is not generally seen in most cases of Mahvash syndrome; this could suggest the possibility of an occult insulinoma. Genetic testing showed an essential splice variant in GCGR that predicts loss of protein production. It is most likely a single pathogenic variant in the GCGR gene, although the literature reports only a recessive phenotype. We cannot entirely exclude an autosomal recessive condition in terms of mutations in promoter or relevant intronic regions.

Endocrine Oncology
Queen Mary University of London (GB), The Royal Free Hospital (GB), City St George's, University of London (GB), University College London (GB)
Openalex Percentile: Top 10%
Pancreatic function and diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon